XGen Pharmaceuticals DJB, Inc.
9 drugs in NADAC|9 Generic,0 Brand
XGen Pharmaceuticals DJB, Inc. lists 9 NDCs in the CMS NADAC file (9 generic, 0 brand), at an average NADAC of $10.30 per unit, with a week-over-week move of -1.8% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
9
9G / 0B
Avg Price / Unit
$10.2974
$0.39 – $20.92
Avg 7d Change
-1.76%
Across 5 drugs with changes
7d Activity
of 9 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
desmopressin acetate market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Factor VIII Activator therapeutic class
Review the broader class where XGen Pharmaceuticals DJB, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does XGen Pharmaceuticals DJB, Inc. make?
XGen Pharmaceuticals DJB, Inc. lists 9 NDCs in the CMS NADAC file — 9 generic and 0 brand products.
What is the average price of XGen Pharmaceuticals DJB, Inc. drugs?
The average NADAC across XGen Pharmaceuticals DJB, Inc.'s portfolio is $10.2974 per unit, ranging from $0.3942 to $20.9230.
What types of drugs does XGen Pharmaceuticals DJB, Inc. make?
XGen Pharmaceuticals DJB, Inc. makes drugs across 10 FDA pharmacologic classes. The most common by NDC count are Factor VIII Activator (2), Vasopressin Analog (2), Phenothiazine (2), Atypical Antipsychotic (1), Lipid-based Polyene Antifungal (1).
Has XGen Pharmaceuticals DJB, Inc. had any drug recalls?
No FDA enforcement recalls are matched to XGen Pharmaceuticals DJB, Inc. in the openFDA feed.
How has XGen Pharmaceuticals DJB, Inc.'s pricing changed recently?
Over the past 7 days, 2 XGen Pharmaceuticals DJB, Inc. products rose and 3 fell, with a portfolio-wide average change of -1.8%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
OLANZAPINE 10 MG VIAL Olanzapine | $20.9230 per EA | -2.08% |
AMPHOTERICIN B 50 MG VIAL Amphotericin B | $20.8740 per EA | — |
DESMOPRESSIN AC 4 MCG/ML VIAL desmopressin acetate | $19.1479 per ML | -6.33% |
DESMOPRESSIN 40 MCG/10 ML VIAL desmopressin acetate | $19.1479 per ML | -6.33% |
NEOMY-POLYMYXIN B 40 MG/ML AMP Neomycin and Polymyxin B Sulfates | $8.1130 per ML | — |
PROMETHAZINE 50 MG/ML AMPUL PROMETHAZINE HYDROCHLORIDE | $2.3389 per ML | — |
PROMETHAZINE 25 MG/ML AMPUL PROMETHAZINE HYDROCHLORIDE | $1.3345 per ML | +1.62% |
TRANEXAMIC ACID 1,000 MG/10 ML Tranexamic Acid | $0.4035 per ML | +4.32% |
ROCURONIUM 50 MG/5 ML VIAL rocuronium bromide | $0.3942 per ML | — |